Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,300 | -263,300 | -112,000 | -27,200 | N/A |
| Depreciation Amortization | 117,800 | 61,900 | 69,600 | 64,600 | N/A |
| Income taxes - deferred | -2,800 | -4,000 | -30,800 | -32,100 | N/A |
| Accounts receivable | -8,700 | -12,500 | -10,300 | -8,800 | N/A |
| Accounts payable and accrued liabilities | 4,700 | -3,700 | -3,500 | 9,200 | N/A |
| Other Working Capital | -54,400 | 10,700 | -101,500 | 120,800 | N/A |
| Other Operating Activity | 62,000 | 100,000 | 82,200 | -107,900 | 0 |
| Operating Cash Flow | $-8,700 | $-110,900 | $-106,300 | $18,600 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,000 | -63,200 | -45,300 | -18,000 | N/A |
| Net Acquisitions | 8,800 | N/A | -57,200 | 379,100 | N/A |
| Purchase Of Investment | 0 | 0 | -103,200 | -147,800 | N/A |
| Sale Of Investment | 9,000 | 105,200 | 128,200 | 61,100 | N/A |
| Purchase Sale Intangibles | -10,700 | -10,100 | 0 | 0 | N/A |
| Other Investing Activity | -10,700 | -10,100 | 0 | 0 | 0 |
| Investing Cash Flow | $-11,900 | $31,900 | $-77,500 | $274,400 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 120,000 | 80,000 | 0 | 0 | N/A |
| Debt Repayment | -119,900 | -40,200 | 0 | -226,400 | N/A |
| Common Stock Issued | 5,900 | 123,600 | 6,300 | 91,800 | N/A |
| Other Financing Activity | -13,400 | -10,500 | -14,300 | -16,000 | 0 |
| Financing Cash Flow | $-7,400 | $152,900 | $-8,000 | $-150,600 | $N/A |
| Exchange Rate Effect | -1,000 | 600 | -600 | -600 | N/A |
| Beginning Cash Position | 140,900 | 66,400 | 258,800 | 117,000 | N/A |
| End Cash Position | 111,900 | 140,900 | 66,400 | 258,800 | N/A |
| Net Cash Flow | $-29,000 | $74,500 | $-192,400 | $141,800 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,700 | -110,900 | -106,300 | 18,600 | N/A |
| Capital Expenditure | -19,000 | -63,200 | -45,300 | -18,000 | N/A |
| Free Cash Flow | -27,700 | -174,100 | -151,600 | 600 | 0 |